Search Results Tagged With Medication

Medication Strategies in Early disease


Common Dopaminergic Medicines in early disease Carbidopa/Levodopa (Sinemet) Dopaminergic agonists Ropinirole (Requip) Pramipexole (Mirapex) Rotigitine (Neupro) MAO B Inhibitors Rasagiline (Azilec…
March 20, 2018

Cholesterol Medication Simvastatin Tested As Potential Treatment For Parkinson's Disease In New Clinical Trial


The Plymouth University Peninsula Schools of Medicine and Dentistry are currently carrying out a clinical trial in which they’re using the treatment on 198 Parkinson’s disease patients who aren’t curr…
January 12, 2016

Parkinson’s patients trained to respond to placebos


The brain cells of people with Parkinson’s disease can be trained to reliably respond to placebo drugs, Italian neuroscientists report. The training wears off after 24 hours but the effect shows it ma…
February 10, 2016

Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease


The U.S. Food and Drug Administration today approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people…
April 29, 2016

Parkinson's Drug Highly Effective for Resistant Depression


Pramipexole (Mirapex, Boehringer Ingelheim Pharmaceuticals, Inc), which is used to treat Parkinson's disease, can significantly improve symptoms of treatment-resistant depression, provided patients ca…
April 07, 2016

Coping With Parkinson's Early


The following is an excerpt from the book Alter The Course. Newly Diagnosed Parkinson's disease. Parkinson’s disease is an unexpected- and unwanted- twist and turn in your life journey. Like any journ…
March 20, 2018

Scientists probing molecular origins of Parkinson's disease highlight two proteins


The two proteins - SATB1 and ZDHHC2 - appear to protect the brain cells most affected by Parkinson's disease. When the proteins become less active, the disease sets in.
August 11, 2015

Antipsychotics for Parkinson's Psychosis May Be Dangerous


A new study from the U.K. finds that antipsychotic drugs may increase the risk of death in people with Parkinson’s disease psychosis (PDP).
October 02, 2015

Parkinson's Disease Drug May Be Useful For Delaying, Preventing Blindness In Older Population


Age-related macular degeneration (AMD) affects as many as 11 million Americans. It’s currently the most common form of blindness among the older population, but a major breakthrough suggests that a dr…
November 10, 2015

Game-Changers in 2015: Parkinson's Disease


New therapies that offer a better way of delivering carbidopa/levodopa were the biggest clinical advance in Parkinson's disease, according to a plurality of experts contacted by MedPage Today. But the…
December 29, 2015

<< Back 1 - 10 of 16 Next >>